Total Payments
$13,126
2024 Payments
$2,203
Companies
45
Transactions
722
Medicare Patients
3,452
Medicare Billing
$371,600
Payment Breakdown by Category
Food & Beverage$13,010 (99.1%)
Education$116.09 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,010 | 718 | 99.1% |
| Education | $116.09 | 4 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,740 | 242 | $0 (2024) |
| Janssen Biotech, Inc. | $1,029 | 67 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $974.46 | 65 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $841.57 | 47 | $0 (2024) |
| Merck Sharp & Dohme LLC | $570.13 | 34 | $0 (2023) |
| Celgene Corporation | $522.60 | 30 | $0 (2023) |
| Gilead Sciences, Inc. | $465.59 | 33 | $0 (2022) |
| NESTLE HEALTHCARE NUTRITION INC. | $450.74 | 22 | $0 (2023) |
| GENZYME CORPORATION | $446.94 | 17 | $0 (2024) |
| PFIZER INC. | $396.61 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,203 | 95 | ABBVIE INC. ($830.94) |
| 2023 | $1,947 | 80 | AbbVie Inc. ($723.70) |
| 2022 | $2,115 | 112 | ABBVIE INC. ($829.30) |
| 2021 | $984.43 | 70 | AbbVie Inc. ($410.22) |
| 2020 | $1,159 | 70 | AbbVie Inc. ($418.18) |
| 2019 | $1,712 | 114 | AbbVie, Inc. ($359.82) |
| 2018 | $1,699 | 103 | AbbVie, Inc. ($590.97) |
| 2017 | $1,306 | 78 | AbbVie, Inc. ($577.03) |
All Payment Transactions
722 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Immunology | ||||||
| 12/18/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $27.74 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Immunology | ||||||
| 12/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: LIVER DISEASE | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.79 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/09/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $37.37 | General |
| Category: LIVER DISEASE | ||||||
| 12/07/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: VIROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: VIROLOGY | ||||||
| 11/13/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $31.02 | General |
| Category: Immunology | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: VIROLOGY | ||||||
| 10/31/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Immunology | ||||||
| 10/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.05 | General |
| Category: Immunology | ||||||
| 10/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: LIVER DISEASE | ||||||
| 09/11/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $99.40 | General |
| Category: LIVER DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 848 | 931 | $277,415 | $87,840 |
| 2022 | 12 | 949 | 1,043 | $298,926 | $100,362 |
| 2021 | 11 | 875 | 981 | $292,959 | $97,890 |
| 2020 | 13 | 780 | 894 | $261,696 | $85,510 |
Total Patients
3,452
Total Services
3,849
Medicare Billing
$371,600
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 108 | 109 | $59,470 | $20,330 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 180 | $40,680 | $16,977 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 182 | $27,890 | $12,294 | 44.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 120 | 121 | $51,889 | $9,048 | 17.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 108 | 108 | $24,516 | $8,294 | 33.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 100 | 104 | $31,533 | $6,267 | 19.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 22 | 22 | $8,624 | $3,975 | 46.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 28 | $12,392 | $3,841 | 31.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 20 | 21 | $8,477 | $2,579 | 30.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 20 | 20 | $7,080 | $2,368 | 33.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 23 | 23 | $3,665 | $1,294 | 35.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 13 | $1,199 | $570.48 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 187 | 260 | $58,761 | $26,118 | 44.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 105 | 106 | $57,464 | $20,640 | 35.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 131 | 131 | $55,937 | $10,896 | 19.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 112 | 112 | $25,312 | $9,590 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 63 | 63 | $21,546 | $8,172 | 37.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 105 | 109 | $32,664 | $7,417 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 110 | $16,830 | $6,598 | 39.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 19 | 19 | $7,448 | $3,640 | 48.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $6,288 | $2,335 | 37.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 50 | 50 | $7,886 | $2,106 | 26.7% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 19 | 19 | $6,726 | $1,944 | 28.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 43 | 48 | $2,064 | $906.86 | 43.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 199 | 293 | $66,238 | $29,488 | 44.5% |
About Dr. John Canio, M.D
Dr. John Canio, M.D is a Gastroenterology healthcare provider based in Roseville, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1598804346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Canio, M.D has received a total of $13,126 in payments from pharmaceutical and medical device companies, with $2,203 received in 2024. These payments were reported across 722 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($13,010).
As a Medicare-enrolled provider, Canio has provided services to 3,452 Medicare beneficiaries, totaling 3,849 services with total Medicare billing of $371,600. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Roseville, CA
- Active Since 02/06/2007
- Last Updated 06/09/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1598804346
Products in Payments
- Humira (Biological) $981.52
- STELARA (Biological) $948.39
- RINVOQ (Biological) $831.78
- XIFAXAN (Drug) $599.05
- HUMIRA (Biological) $593.06
- SKYRIZI (Biological) $536.88
- ZEPOSIA (Drug) $522.60
- ZENPEP (Drug) $491.87
- DUPIXENT (Biological) $491.14
- MAVYRET (Drug) $483.74
- XELJANZ (Drug) $383.98
- DIFICID (Drug) $342.34
- LINZESS (Drug) $334.61
- ENTYVIO (Biological) $325.85
- Entyvio (Biological) $307.64
- Sucraid (Drug) $304.37
- CREON (Drug) $296.48
- TRULANCE (Drug) $269.53
- ESOPHYX (Device) $232.29
- Amitiza (Drug) $207.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Roseville
Ronald Hsu, Md, MD
Gastroenterology — Payments: $117,905
Gastroenterology $117,905
Dr. Anand Madan, M.d, M.D
Gastroenterology — Payments: $26,461
Gastroenterology $26,461
Randell Vallero, Md, MD
Gastroenterology — Payments: $20,029
Gastroenterology $20,029
Jasbir Rangi, Md, MD
Gastroenterology — Payments: $17,959
Gastroenterology $17,959
Rakesh Parikh, Md, MD
Gastroenterology — Payments: $13,384
Gastroenterology $13,384
Dr. Rahul Dhillon, M.d, M.D
Gastroenterology — Payments: $4,456
Gastroenterology $4,456